Job Description
Pharmacovigilance Project Lead - solid pharmacovigilance and drug safety experience needed - Bulgaria
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
As a **Pharmacovigilance Project Lead** at ICON, you will oversee the strategic management of safety monitoring and reporting for clinical trials and post-marketing activities.
**What You Will Do:**
You will oversee **pharmacovigilance and drug safety workstreams** , ensuring deliverables meet quality and timeline expectations.
Key responsibilities include:
+ Leading and managing pharmacovigilance projects, including overseeing safety data collection, evaluation, and reporting processes.
+ Developing and implementing strategies to ensure the effective management of advers...
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
As a **Pharmacovigilance Project Lead** at ICON, you will oversee the strategic management of safety monitoring and reporting for clinical trials and post-marketing activities.
**What You Will Do:**
You will oversee **pharmacovigilance and drug safety workstreams** , ensuring deliverables meet quality and timeline expectations.
Key responsibilities include:
+ Leading and managing pharmacovigilance projects, including overseeing safety data collection, evaluation, and reporting processes.
+ Developing and implementing strategies to ensure the effective management of advers...
Ready to Apply?
Submit your application today and join our talented team at ICON Clinical Research.
Submit ApplicationJob Details
- Location Sofia, Bulgaria
- Job Type Full-time
- Category other-general
- Posted Date June 03, 2026
- Application Deadline June 08, 2026